𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of subcutaneous and intracranial brain tumor xenografts withO6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea

✍ Scribed by G. Michael Felker; Henry S. Friedman; M. Eileen Dolan; Robert C. Moschel; Clifford Schold


Publisher
Springer
Year
1993
Tongue
English
Weight
737 KB
Volume
32
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Production of stable phenotypes from 9L
✍ Mary-Helen Barcellos-Hoff; Peter A. Linfoot; Laurence J. Marton; Dennis F. Deen πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 French βš– 566 KB

## Abstract During chemotherapy and regrowth of brain tumors, tumor‐cell heterogeneity, and possibly tumor progression, may change as a result of both the selective forces and mutagenic effects of treatment. We have isolated and characterized drug‐response variants of multicellular rat 9L brain‐tum

Differential response to 1,3-bis (2-chlo
✍ Karl J. Hunter; Dennis F. Deen; Laurence J. Marton πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 French βš– 325 KB

Pretreatment of 9L cells with either a-difluoromethylornithine (DFMO), which depletes intracellular levels of polyamines, or 6-thioguanine (6TG). which substitutes for guanine in DNA, potentiates the cytotoxic effects of 1,3-bis (2-chloroethy1)-I -nitrosourea (BCNU). We examined the effects of these